BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25

• Press Releases

  Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025

  July 23, 2025

   · 

  2 min read
• Press Releases

  uniQure to Announce Second Quarter 2025 Financial Results

  July 23, 2025

   · 

  1 min read
• Press Releases

  European Commission approves IMBRUVICA® (ibrutinib) as the first targeted therapy for patients with previously untreated mantle cell lymphoma who would be eligible for autologous stem cell transplant

  July 23, 2025

   · 

  10 min read
• Press Releases

  4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

  July 23, 2025

   · 

  4 min read
• Press Releases

  Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

  July 23, 2025

   · 

  4 min read
• Press Releases

  Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

  July 23, 2025

   · 

  2 min read
• Press Releases

  Senzime’s TetraGraph System Receives Regulatory Approval in Mexico

  July 23, 2025

   · 

  1 min read
• Press Releases

  Corstasis Therapeutics Announces Appointment of Sanjeev Narula to its Strategic Advisory Board

  July 23, 2025

   · 

  2 min read
• Press Releases

  European Commission approves DARZALEX® (daratumumab) as the first licensed treatment for patients with high-risk smouldering multiple myeloma

  July 23, 2025

   · 

  14 min read
• Press Releases

  European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation

  July 23, 2025

   · 

  11 min read